| Price | $0.56 |
| Year Range | $0.34 – $1.48 |
| Market Cap | $19M |
| Industry | Biotechnology |
What Is Jasper Therapeutics’s AI Stock Analysis?
Jasper Therapeutics’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Jasper Therapeutics’s momentum in near-real time.
Jasper Therapeutics (JSPR) has an AltIndex AI Score of 53/100, currently a Hold signal. The AI Score distills Jasper Therapeutics's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Jasper Therapeutics’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Jasper Therapeutics — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving JSPR’s AI Score?
Fundamentals
Net income for the last quarter was $-2.8M. This represents a decrease of 135.09% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -89.67%, suggesting positive year-over-year growth. Ebitda for the last quarter was $-2.8M. This represents a decrease of 139.38% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of -89.57%, suggesting positive year-over-year growth.
See Jasper Therapeutics’s earnings and insider transactions.
Technicals
Today's stock price is $0.56. This represents a decrease of 20.00% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 76.67%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $0.57, which is lower than the previous SMA10 of $0.58. This suggests a potential downward trend in price movement. The RSI is 47.8, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Jasper Therapeutics has an estimate of 5,000 visitors to their webpage. The number of visitors is up by 67% in the last couple of months, a bullish trend as this can indicate can increase in customers.
Explore Jasper Therapeutics’s job postings, web traffic and app downloads.
Frequently Asked Questions: Jasper Therapeutics AI Stock Analysis
Jasper Therapeutics's AltIndex AI Score is 53/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Jasper Therapeutics a Hold (53/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Jasper Therapeutics — company overview, fundamentals, technicals and alternative data, with a recommendation. See the JSPR AI Score or sign up to read the full thesis.
